Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBP) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Regen BioPharma (RGBP) over the last 13 years, with Q4 2025 value amounting to -$64977.0.

  • Regen BioPharma's Net Cash Flow fell 1110293.1% to -$64977.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $4442.0, marking a year-over-year increase of 10357.18%. This contributed to the annual value of $68839.0 for FY2025, which is 15721.28% up from last year.
  • As of Q4 2025, Regen BioPharma's Net Cash Flow stood at -$64977.0, which was down 1110293.1% from $67794.0 recorded in Q3 2025.
  • In the past 5 years, Regen BioPharma's Net Cash Flow registered a high of $538983.0 during Q3 2021, and its lowest value of -$373670.0 during Q4 2021.
  • Moreover, its 5-year median value for Net Cash Flow was -$10463.0 (2022), whereas its average is -$1074.8.
  • In the last 5 years, Regen BioPharma's Net Cash Flow surged by 24193.64% in 2023 and then plummeted by 1110293.1% in 2025.
  • Quarter analysis of 5 years shows Regen BioPharma's Net Cash Flow stood at -$373670.0 in 2021, then surged by 97.2% to -$10463.0 in 2022, then surged by 133.08% to $3461.0 in 2023, then crashed by 116.76% to -$580.0 in 2024, then crashed by 11102.93% to -$64977.0 in 2025.
  • Its Net Cash Flow stands at -$64977.0 for Q4 2025, versus $67794.0 for Q3 2025 and -$1.0 for Q2 2025.